选择性胎儿生长受限的双绒毛膜双羊膜囊双胎妊娠中的先天性心脏缺陷
该回顾性研究纳入2009至2018年870例单绒毛膜双羊膜囊双胎妊娠,其中选择性胎儿生长受限组296例、无并发症组574例。选择性胎儿生长受限组先天性心脏缺陷患病率为3.7%(22/592胎),显著高于无并发症组的1.1%(13/1148胎)(P=0.0002;OR 3.57,95%CI 1.78-7.22)。作者建议此类孕妇转诊至三级医院进行产前及产后心脏评估、治疗和长期随访。
要点
- 选择性胎儿生长受限组先心病患病率3.7%,显著高于无并发症组的1.1%(P=0.0002;OR 3.57,95%CI 1.78-7.22)。
- 大胎中11例先心病有10例(91%)为右心室流出道异常,小胎中11例先心病涵盖广泛心脏异常。
- 所有先心病病例均表现为双胎不一致,未见仅小胎受累的III型选择性胎儿生长受限妊娠。
核心结论
- 在单绒毛膜双羊膜囊双胎妊娠中,选择性胎儿生长受限与先心病患病率增高约三倍相关。
研究设计与样本
- 回顾性分析2009至2018年连续转诊的单绒毛膜双羊膜囊双胎妊娠,选择性胎儿生长受限组296例、无并发症组574例,共870例;所有在本中心分娩的新生儿出院前筛查先心病,院外分娩者调取出院记录;选择性胎儿生长受限按Gratacós分型分为三型。
关键影像表现/征象
- 大胎中11例先心病有10例(91%)为右心室流出道异常,1例(9%)为室间隔缺损。
- 小胎中11例先心病涵盖广泛心脏异常。
- 4例III型选择性胎儿生长受限合并先心病中,1例大胎为肺动脉狭窄、小胎为孤立性主动脉缩窄,3例仅大胎为肺动脉狭窄。
诊断标准与关键数值
- 选择性胎儿生长受限组先心病患病率3.7%(22/592胎),三型间无显著差异(I型3.7%、II型3.2%、III型4.2%;P=0.55)。
- 无并发症组先心病患病率1.1%(13/1148胎),与同期同地区EUROCAT登记的普通人群0.96%相似(P=0.579)。
- 选择性胎儿生长受限组较无并发症组先心病患病率显著增高(3.7% vs 1.1%;P=0.0002;OR 3.57,95%CI 1.78-7.22)。
临床应用与阅片要点
- 作者认为,合并选择性胎儿生长受限的单绒毛膜双羊膜囊双胎妊娠孕妇应转诊至三级医院进行产前及产后心脏评估、治疗和长期随访。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVES: To evaluate the prevalence, subtypes and postnatal outcomes of congenital heart defects (CHD) in a cohort of monochorionic diamniotic (MCDA) twin pregnancies complicated by selective fetal growth restriction (sFGR), and to compare this population with a cohort of uncomplicated MCDA pregnancies evaluated during the same period.
METHODS: This was a retrospective analysis of all consecutive MCDA pregnancies referred between 2009 and 2018, including those complicated by sFGR (Group A) and those without complications (Group B). All neonates delivered in our center were screened for CHD before discharge. Discharge letters for all those delivered elsewhere were retrieved. Pregnancies with complications other than sFGR and those without perinatal follow-up were excluded. Pregnancies in Group A were divided into three types according to the Gratacós system of sFGR classification.
RESULTS: A total of 870 MCDA twin pregnancies were included: 296 in Group A and 574 in Group B. In Group A, the prevalence of CHD was 3.7% (22/592 twins), with no significant difference in CHD frequency between the three types of sFGR (Type I, 3.7%; Type II, 3.2%; Type III, 4.2%; P = 0.55). Of four Type-III sFGR pregnancies with CHD, one had pulmonary stenosis (PS) in the larger twin and isolated coarctation of the aorta in the smaller cotwin, and three had PS in the larger twin only. No Type-III sFGR pregnancies in which only the smaller twin was affected by CHD were observed. Of 11 CHD cases in the larger twin, 10 (91%) were right ventricular outflow tract abnormalities (RVOTA), and one (9%) was a ventricular septal defect. In the smaller twins, 11 cases of CHD were observed, covering a broad spectrum of cardiac abnormalities. In Group B, the CHD prevalence was 1.1% (13/1148 twins), which was similar to that in the general population, according to the EUROCAT registry for the same period and geographical area of the study (0.96%; P = 0.579). The CHD prevalence was significantly higher in Group A compared with Group B (3.7% vs 1.1%; P = 0.0002; odds ratio, 3.57 (95% CI, 1.78-7.22)). In all pregnancies with CHD in the study population, the anomaly was discordant.
CONCLUSIONS: In MCDA twin pregnancy, sFGR was associated with a three-fold higher prevalence of CHD. Women with such pregnancies should be referred to a tertiary care hospital for pre- and postnatal cardiac evaluation, treatment and long-term follow-up. In larger twins, the only major CHD observed was RVOTA, while a broad spectrum of CHD was noted in smaller twins. The higher risk of CHD in MCDA pregnancies appears to be due to the typical complications of the monochorionic pregnancy, rather than to the monochorionic nature of the pregnancy itself. © 2022 International Society of Ultrasound in Obstetrics and Gynecology.
引用
- Faiola S, Casati D, Nelva Stellio L, et al. Congenital heart defects in monochorionic twin pregnancy complicated by selective fetal growth restriction. Ultrasound Obstet Gynecol. 2023. PMID: 36273402. doi:10.1002/uog.26098
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。